bluebird bio Inc.

In News

bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots - Business Wire

Business Wire - Sep 18, 2025

After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics - Fierce Pharma

Fierce Pharma - Sep 18, 2025

Bluebird bio flies to pastures new with Genetix rebranding - Pharmaceutical Technology

Pharmaceutical Technology - Sep 19, 2025

bluebird bio, Inc. (BLUE) Nears Acquisition by Carlyle and SK Capital - Yahoo Finance

Yahoo Finance - May 30, 2025

Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital - Reuters

Reuters - May 14, 2025

bluebird bio acquired to scale gene therapy access - investing.com

investing.com - Jun 02, 2025

bluebird bio, Inc. SEC 10-Q Report - TradingView

TradingView - May 14, 2025

The Truth About bluebird bio Inc (BLUE): Tiny Stock, Huge Drama – Is This Biotech Comeback Real or - AD HOC NEWS

AD HOC NEWS - Feb 05, 2026

Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio - BioSpace

BioSpace - May 06, 2025

Press Release Service: Advanced Therapy Medicinal Products Global Strategic Business Report 2025, with Profiles of Bluebird Bio, Gilead Sciences, JCR Pharmaceuticals, Kolon TissueGene, MediPost, Organogenesis and more - ResearchAndMarkets.com - CRISPR Medicine News

CRISPR Medicine News - Apr 21, 2025

Bluebird Bio (BLUE) Acquired by Carlyle and SK Capital Partners | BLUE Stock News - GuruFocus

GuruFocus - Jun 02, 2025

bluebird bio Bolsters Management Team with Appointments - Contract Pharma

Contract Pharma - Jul 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment